Outlook Therapeutics, Inc. (Nasdaq:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will ...

RTMNF [ Q1 Net revenues decreased 4.1% to C$158.9 million, primarily due to severe winter weather in the month of February and economic uncertainty. * Comparable sales1 decreased 4.5%. * Gross profit ...

Investing.com - A lack of actionable changes to Medicaid and state and local tax provisions in the U.S. Senate’s version of a sweeping tax-and-spending bill overshadowed improve ...

Amazon.com (AMZN), Alphabet's (GOOG, GOOGL) Google, Microsoft (MSFT), and Meta Platforms (META) are PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold ...

Univar Solutions Belgium Wednesday reported [ expansion of the partnership between their Foodology by Univar Solutions business and Ingredion (NYSE:INGR [ which provides ingredients for the food and ...

Analysis-Early Fed chair nomination could rattle markets ...

BTDR [ on Wednesday announced [ the pricing of $330 million principal amount of 4.875% Convertible Senior Notes due 2031 in a private placement. * The company has also granted the initial purchasers ...

What is shaping recent developments around Simon Property Group (NYSE:SPG) on the S&P 500 and NYSE Composite? Explore the latest sector updates tied to real estate operations and portfolio performance ...

What’s driving attention to Nutrien (NYSE:NTR) on NYSE and the S&P 500 Index? Explore recent developments involving ...

Explore recent developments surrounding Leidos Holdings (NYSE:LDOS), a defense technology company listed on the NYSE and part of the S&P 500 Index, with updated institutional observations.

(Reuters) -Airbus said on Wednesday that it will extend its upper range of its dividend payout to 30%-50% from the current payout ratio of 30%-40%. The company said that its guidance for 2025 remains ...

Lifecore Biomedical, Inc. (LFCR) has entered a 10-year commercial manufacturing and supply agreement with an existing partner to advance a new ophthalmic treatment through clinical stages to market ...